Trial intelligence / Profile preview

Allogeneic Transplant with Mini-Conditioning for Stage IV Breast Cancer

NCT00006261Phase 2Withdrawn

Sponsor
Case Comprehensive Cancer Center
Start
May 2000
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of donor lymphocyte infusion in breast cancer, sponsored by Case Comprehensive Cancer Center. Planned start May 2000; status: withdrawn.

02

Drugs

donor lymphocyte infusion
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00006261.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00006261.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call